The Group communicates that it has signed new agreements with Casa Marzam S.A. and with Zentiva K.S. to distribute its […]
The Group’s senior management presented its results and new development prospects to the financial community, which met for the Italian […]
The food supplement market is growing in Italy and SiderAL® Forte 20 capsules is the most sold nutritional supplement in […]
Publication of the start of coverage survey drafted by Mediobanca; declaring a target price at €24.50. PharmaNutra S.p.A. has […]
International recognition continues for PharmaNutra, which, whilst commercially experiencing a strong and constant expansion in foreign markets, also continues, from […]
Sorry, this entry is only available in Italiano. Con il suo brand Cetilar®, PharmaNutra affiancherà per il primo anno il […]
The Group obtains approval of two new patents for the Sucrosomial® Technology and signs a distribution agreement for the SiderAL® […]
Specifico per la cura e l’igiene di palpebre e ciglia, il nuovo prodotto è stato presentato in occasione della Convention […]
The new patent, valid until 2037, opens PharmaNutra up to the possibility of developing specific products for the cardiovascular field, […]
CPhI Worldwide 2019 was held from 5ᵗʰ to 7ᵗʰ November: three days dedicated to the best of global pharma, during […]
Sorry, this entry is only available in Italiano. Apre oggi il CPhI Worldwide 2019 di Francoforte: PharmaNutra tra le aziende […]
After Europe, the intellectual property rights of the patent expiring in 2033 are now acknowledged in the United States. A […]